A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains

Protein Engineering, Design and Selection

Volumn 24, Issue 3, 2011, Pages 291-299

  Pan, Keyao ^a   Subieta, Krystina C ^c   Deem, Michael W ^a,b  

^a Rice University   (United States)

^b RICE UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

antigenic distance; antigenic drift; influenza; pepitope; vaccine effectiveness

Indexed keywords

ANIMAL MODEL; ANTIGENIC DISTANCE; ANTIGENIC DRIFT; DISTANCE MEASURE; EVOLUTION RATE; IMMUNE RESPONSE; IMMUNE SELECTION; INFLUENZA; INFLUENZA PANDEMICS; INFLUENZA VACCINES; INHIBITION ASSAYS; PEPITOPE; VACCINE STRAINS; VIRUS STRAINS;

ANTIGENS; VIRUSES;

VACCINES;

EPITOPE; INFLUENZA VACCINE;

ADULT; ANTIGENICITY; ARTICLE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; PRIORITY JOURNAL; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY;

ANIMALIA; MUSTELA;

EID: 79951901359     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzq105     Document Type: Article

References (43)

1. 291-299, Belongia, E., Kieke, B., Coleman, L., et al. (2008) J. Am. Med. Assoc., 299, 2381-2384.
2. Brown, I.H., Harris, P.A., McCauley, J.W. and Alexander, D.J. (1998) J. Gen. Virol., 79, 2947-2955.
3. Caton, A.J., Brownlee, G.G., Yewdell, J.W. and Gerhard, W. (1982) Cell, 31, 417-427.
4. Centers for Disease Control and Prevention (CDC) (2009a) MMWR Morb. Mortal. Wkly. Rep., 58, 1241-1245.
5. Centers for Disease Control and Prevention (CDC) (2009b) MMWR Morb. Mortal. Wkly. Rep., 58, 1009-1012.
6. Centers for Disease Control and Prevention (CDC) (2009c) MMWR Morb. Mortal. Wkly. Rep., 58, 1236-1241.
7. Centers for Disease Control and Prevention (CDC) (2009d) MMWR Morb. Mortal. Wkly. Rep., 58, 369-374.
8. Chakraverty, P., Cunningham, P., Shen, G.Z. and Pereira, M.S. (1986) J. Hyg. Camb., 97, 347-358.
9. Couch, R.B., Quarles, J.M., Cate, T.R. and Zahradnik, J.M. (1986) In Kendal, A.P. and Patriarca, P.A. (eds), Options for the Control of Influenza, UCLA Symposia on Molecular and Cellular Biology, Vol. 36. Alan R. Liss, New York, pp. 223-241.
10. Couch, R.B., Keitel, WA., Cate, T.R., Quarles, JA., Taber, LA. and Glezen, W.P. (1996) In Brown, L.E., Hampson, A.W. and Webster, R.G. (eds), Options for the Control of influenza III. Elsevier Science B.V., Amsterdam., pp. 97-106.
11. Cox, N., Balish, A., Brammer, L., et al. (2003) Information for the Vaccines and Related Biological Products Advisory Committee, CBER, FDA. WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza. Atlanta, USA.
12. Cox, N., Balish, A., Berman, L., et al. (2007) Information for the Vaccines and Related Biological Products Advisory Committee, CEBR, FDA. WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza. Atlanta, USA.
13. Daniels, R.S., Douglas, A.R., Skehel, J.J. and Wiley, D.C. (1985) Bull. World Health Organ., 63, 273-277.
14. Deem, M.W. and Lee, H.Y. (2003) Phys. Rev. Lett., 91, 068101.
15. Deem, M.W. and Pan, K. (2009) Protein Eng., Des. Sel., 22, 543-546.
16. Donatelli, I., Campitelli, L., Ruggieri, A., Castrucci, M.R., Calzoletti, L. and Oxford, J.S. (1993) Eur. J. Epidemiol., 9, 241-250.
17. Edwards, K.M., Dupont, W.D., Westrich, M.K., Plummer, W.D., Palmer, P.S. and Wright, P.F. (1994) J. Infect. Dis., 169, 68-76.
18. Ferguson, N.M., Galvani, A.P. and Bush, R.M. (2003) Nature, 422, 428-433
19. Note the standard error of the evolution rate is misprinted, and we use the corrected value of 10-4.
20. Grotto, I., Mandel, Y., Green, M.S., Varsano, N., Gdalevich, M. and Ashkenazi, I. (1998) Clin. Infect. Dis., 26, 913-917.
21. Gupta, V., Earl, D.J. and Deem, M.W. (2006) Vaccine, 24, 3881-3888.
22. Hay, A.J., Gregory, V., Douglas, A.R. and Lin, Y.P. (2001) Phil. Trans. R. Soc. Lond. B, 356, 1861-1870.
23. Keitel, WA., Cate, T.R. and Couch, R.B. (1988) Am. J. Epidemiol., 127, 353-364.
24. Keitel, WA., Cate, T.R., Couch, R.B., Huggins, L.L. and Hess, K.R. (1997) Vaccine, 15, 1114-1122.
25. Kendal, A.P., Cox, N.J. and Harmon, M.W. (1990) In Kurstak, E., Marusyk, R. G., Murphy, F. A. and van Regenmortel, M. H. V. (eds), Applied Virology Research: Virus Variability, Epidemiology and Control. Springer, pp. 119-130.
26. Lee, M.S. and Chen, J.S. (2004) Emerg. Infect. Dis., 10, 1385-1390.
27. Macken, C., Lu, H., Goodman, J. and Boykin, L. (2001) In Osterhaus, A.D.M.E., Cox, N. and Hampson, A.W. (eds), Options for the Control of Influenza IV. Elsevier; accession number ISDN38157. http://www.flu.lanl.gov/.
28. Nobusawa, E. and Sato, K. (2006) J. Virol., 80, 3675-3678.
29. Pan, K. and Deem, M.W. (2009) Vaccine, 27, 5033-5034.
30. Rambaut, A., Pybus, O.G., Nelson, M.I., Viboud, C., Taubenberger, J.K. and Holmes, E.C. (2008) Nature, 453, 615-619.
31. Rimmelzwaan, G.F., de Jong, J.C., Bestebroer, T.M., van Loon, A.M., Claas, E.C.J., Fouchier, RA.M. and Osterhaus, A.D.M. (2001) Virology, 282, 301-306.
32. Skowronski, D.M., De Serres, G., Crowcroft, N., Janjua, N., Boulianne, N., Hottes, T.S. and Rosella, L.C. (2010) Int. J. Infect. Dis., S114, e321-e322.
33. Smith, D.J., Forrest, S., Ackley, D.H. and Perelson, A.S. (1999) Proc. Natl Acad. Sci. USA, 96, 14001-14006.
34. Smith, D.J., Lapedes, A.S., de Jong, J.C., Bestebroer, T.M., Rimmelzwaan, G.F., Osterhaus, A.D.M.E. and Fouchier, RA.M. (2004) Science, 305, 371-376.
35. Sun, J., Earl, D.J. and Deem, M.W. (2006) Mod. Phys. Lett. B, 20, 63-95.
36. Treanor, J.J., Kotloff, K., Betts, R.F., Belshe, R., Newman, F, Iacuzio, D., Wittes, J. and Bryant, M. (1999) Vaccine, 18, 899-906.
37. Wang, Z., Tobler, S., Roayaei, J. and Eick, A. (2009) J. Am. Med. Assoc., 301, 945-953.
38. WHO (1984) Wkly. Epidemiol. Rec., 59, 53-60.
39. WHO (1986) Wkly. Epidemiol. Rec., 61, 237-244.
40. WHO (1992) Wkly. Epidemiol. Rec., 67, 57-64.
41. WHO Collaborating Center for Surveillance, e. and Control of Influenza (2008) Preliminary Information for the Vaccines and Related Biological Products Advisory Committee. CEBR, FDA.
42. Wiley, D.C., Wilson, I.A. and Skehel, J.J. (1981) Nature, 289, 373-378.
43. Zaraket, H., Saito, R., Sato, I., Suzuki, Y., Li, D.J., Dapat, C., Caperig-Dapat, I., Oguma, T., Sasaki, A. and Suzuki, H. (2009)Arch. Virol., 154, 285-295.